Malaysia
Medical device registration in Malaysia is mandatory for any medical device imported, exported, or placed on the Malaysian market. The Medical Device Authority (MDA), an agency under the Ministry of Health, administers the registration system. Foreign manufacturers must work through a licensed local Malay Authorized Representative, and most devices require a technical review by a registered Conformity Assessment Body (CAB) before the MDA grants approval.
Medical Device Classification in Malaysia
Malaysia uses a four-tier, risk-based classification system aligned with the ASEAN Medical Device Directive. Classification determines the registration route, the level of CAB review, and the applicable fees.
- Class A: low risk, such as non-sterile bandages and tongue depressors
- Class B: low to moderate risk, such as hypodermic needles and suction equipment
- Class C: moderate to high risk, such as lung ventilators and orthopedic implants
- Class D: high risk, such as heart valves and implantable defibrillators
The classification rules consider the duration of contact with the body, the degree of invasiveness, and whether the device is active. In vitro diagnostic (IVD) devices follow a separate set of rules within the same Class A to D structure. Since May 2025, manufacturers complete classification online through the MDA portal, and the MDA no longer accepts physical submissions.
Authorized Representative and Establishment Licensing
Foreign manufacturers cannot submit applications on their own to the MDA directly. Instead, they must appoint a Malaysian Authorized Representative (AR) that acts as the manufacturer’s local agent for registration and post-market activities. The AR holds the registration in the MDA’s Medical Device Centralized Online Application System (MeDC@St).
The AR must hold an MDA establishment licence. Manufacturers, importers, distributors, and ARs all require this licence, while retailers are exempt. Licence holders must comply with Good Distribution Practice for Medical Devices (GDPMD).
Manufacturers can appoint a subsidiary, a distributor, or an independent third party as their AR. An independent AR allows the manufacturer to change distributors easily without transferring its device registrations.
The Malaysia Medical Device Registration Process
The registration process for Class B, C, and D devices follows four main steps.
- Appoint a licensed AR and confirm the device classification.
- Prepare the technical dossier in the Common Submission Dossier Template (CSDT) format. The CSDT includes the device description, intended use, Essential Principles checklist, risk management file, clinical evidence, labeling and instructions for use, manufacturing information, quality management system certificates such as ISO 13485, and Declaration of Conformity (either MDA or EU format).
- Submit the technical dossier to an MDA-registered CAB for conformity assessment. The CAB reviews the technical documentation and issues a conformity assessment certificate.
- Submit the registration application, CAB certificate, and supporting documents through MeDC@St. The MDA then reviews the application and, if it approves, lists the device in the Malaysia Medical Device Register.
Class A devices do not require CAB assessment. The AR submits the application directly to the MDA through MeDC@St. If the MDA returns an application for corrections, the applicant has 90 days to resubmit.
Conformity Assessment by Verification
Devices already approved by a recognized reference regulator can follow a verification route, in which the CAB conducts an abridged review. The MDA’s second revised guidance, effective September 30, 2025, recognizes eight reference regulators: EU Notified Bodies, Japan MHLW, Australia TGA, Health Canada, US FDA, UK MHRA, Singapore HSA, and Thailand FDA.
Moreover, the MDA and Singapore’s Health Sciences Authority (HSA) ran a reliance pilot from September 1, 2025, to February 28, 2026. As of March 1, 2026, Class B, C, and D devices registered on the Singapore Medical Device Register can use the verification route in Malaysia on a permanent basis.
In addition, Malaysia became a member of the Medical Device Single Audit Program (MDSAP) in September 2025. As a result, manufacturers and ARs can use MDSAP certificates and audit reports in pre-market submissions to the MDA.
Timelines and Registration Validity
Registration timelines depend on the device class and the conformity assessment route. Industry estimates place Class A registration at approximately 1.5 to 2 months. For Class B, C, and D devices, the verification route (CAB review process) takes approximately 4 to 6 months, and the full conformity assessment route (MDA review process) takes approximately 6 to 9 months. These estimates do not include preparation time to complete the dossier.
A Malaysia medical device registration is valid for five years. On July 13, 2026, the MDA launched an Automated Re-Registration Route for renewal applications. Under this route, the AR uploads the required documents, including current QMS certificates, updated labeling, five years of post-market and vigilance data, and, for Class B to D devices, a valid CAB certificate and updated clinical evaluation report. After the applicant pays the fees, the system issues the certificate without further MDA review. Applicants cannot use this route while a change application is currently active.
Post-Market Obligations
ARs must maintain post-market surveillance, complaint handling, distribution records, and field safety corrective action procedures. Under the MDA’s Mandatory Problem Reporting requirements, establishments must submit an initial report within 48 hours, 10 days, or 30 days of becoming aware of a reportable incident, depending on its severity. An investigation report follows within 30 days of the initial report.
Key Takeaways for Foreign Medical Device Companies
Malaysia medical device registration requires foreign manufacturers to appoint a licensed AR, classify the device under the Class A to D system, prepare a CSDT dossier, and obtain CAB conformity assessment before the MDA grants approval. Several recent changes have shortened this process for many device manufacturers. Therefore, device manufacturers that select their AR registration route and dossier strategy early can reduce delays in reaching the relatively large Malaysian market.
Written by: Ames Gross – President and Founder, Pacific Bridge Medical (PBM)
Mr. Gross founded PBM in 1988 and has helped hundreds of medical companies with regulatory and business development issues in Asia. He is recognized nationally and internationally as a leader in the Asian medical markets. Mr. Gross has a BA degree, Phi Beta Kappa, from the University of Pennsylvania and an MBA from Columbia University.